Quantitative effect of TAS2R agonists on [Ca²⁺]_i in HASM stimulated by five GPCR agonists. by Blanca Camoretti-Mercado (762326)

Sema3a inhibits the differentiation of Raw264.7 cells to osteoclasts under 2Gy radiation by reducing inflammation by Bo Huang (30906)

“…Raw264.7 cells were divided into four groups: A, receiving no radiation; B, receiving no radiation + 50ngng/ml Sema3a; C, receiving 2Gy radiation; and D, receiving 2Gy radiation +50ngng/ml Sema3a. …”

Synthesis of Triazole-Substituted Quinazoline Hybrids for Anticancer Activity and a Lead Compound as the EGFR Blocker and ROS Inducer Agent by Biswadip Banerji (482320)

“…A series of triazole-substituted quinazoline hybrid compounds were designed and synthesized for anticancer activity targeting epidermal growth factor receptor (EGFR) tyrosine kinase. …”

4‑Aminoquinoline Antimalarials Containing a Benzyl­methyl­pyridyl­methyl­amine Group Are Active against Drug Resistant <i>Plasmodium falciparum</i> and Exhibit Oral Activity in Mic... by Mukesh C. Joshi (4670284)

“…These compounds exhibited significantly improved solubility and decreased lipophilicity and were potent against chloroquine-sensitive (NF54) and -resistant (Dd2 and 7G8) <i>P. falciparum</i> strains with 5/6 having IC₅₀ < 100 nM against the NF54 strain. …”

16 Weeks of Progressive Barefoot Running Training Changes Impact Force and Muscle Activation in Habitual Shod Runners by Ana Paula da Silva Azevedo (3373688)

“…The magnitude of first peak of VGRF (Fy1) and the impulse of the first 50 ms decreased after training for BF and SH (p<0.01). …”

Heat map and volcano plot of the GSE85618 dataset. by Hanhan Liu (568151)

A map of the Bangkok metropolitan area where the study participants (cats and dogs) were from (the green color is the area of residence of the dogs and cats used in this study) [25... by Chanon Fa-ngoen (18121319)

Kinetics and dose response of distinct changes to HDMEC barriers induced by TNF and IL-β. by Paul R. Clark (714064)

“…B: TNF induction of an early TEER rise and a bi-phasic TEER decrease. Labels indicate the peak of the early TEER increase and two distinct phases of TEER decrease (as nadirs to phases 1 and 2). …”

Apoptosis is induced in EYFP-LIPT2 and ΔmitotagLIPT2 expressing cells. by Emanuele Bernardinelli (4117372)

Attenuation of Quorum Sensing Regulated Virulence of <i>Pectobacterium carotovorum</i> subsp. <i>carotovorum</i> through an AHL Lactonase Produced by <i>Lysinibacillus</i> sp. Gs50 by Sneha S. Garge (3375242)

“…Our results demonstrate the potential of <i>Lysinibacillus</i> sp. Gs50 as a preventive and curative biocontrol agent.…”

Initial treatment regimen. by Shivani Patel (4742748)

“…Hedgehog inhibition (HHI) with vismodegib or sonidegib induces a 50–60% response rate. Long-term toxicity includes muscle spasms and weight loss leading to dose decreases. …”

Patients baseline characteristics. by Shivani Patel (4742748)

“…Hedgehog inhibition (HHI) with vismodegib or sonidegib induces a 50–60% response rate. Long-term toxicity includes muscle spasms and weight loss leading to dose decreases. …”

Overall survival. by Shivani Patel (4742748)

“…Hedgehog inhibition (HHI) with vismodegib or sonidegib induces a 50–60% response rate. Long-term toxicity includes muscle spasms and weight loss leading to dose decreases. …”

Progression-free survival by treatment. by Shivani Patel (4742748)

“…Hedgehog inhibition (HHI) with vismodegib or sonidegib induces a 50–60% response rate. Long-term toxicity includes muscle spasms and weight loss leading to dose decreases. …”

Maintenance regimen and adverse event management. by Shivani Patel (4742748)

“…Hedgehog inhibition (HHI) with vismodegib or sonidegib induces a 50–60% response rate. Long-term toxicity includes muscle spasms and weight loss leading to dose decreases. …”

BCC-specific survival. by Shivani Patel (4742748)

“…Hedgehog inhibition (HHI) with vismodegib or sonidegib induces a 50–60% response rate. Long-term toxicity includes muscle spasms and weight loss leading to dose decreases. …”

Inverse Simpson index (A) and richness (B) shown for the post-operative and perioperative groups. by Allison J. Collier (13977858)

Outcome of AEFIs. by Amma Frempomaa Asare (19751343)

“…Relative to those 50 years and above, the odds of serious AEFI were 60% less among those aged <30 years (aOR = 0.40, CI: [0.19, 0.86], p = 0.019). …”

Types of AEFIs reported by vaccine type in Ghana. by Amma Frempomaa Asare (19751343)

“…Relative to those 50 years and above, the odds of serious AEFI were 60% less among those aged <30 years (aOR = 0.40, CI: [0.19, 0.86], p = 0.019). …”

Types of AEFIs reported. by Amma Frempomaa Asare (19751343)

“…Relative to those 50 years and above, the odds of serious AEFI were 60% less among those aged <30 years (aOR = 0.40, CI: [0.19, 0.86], p = 0.019). …”